{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:01:08Z","timestamp":1769508068880,"version":"3.49.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00210-024-02947-6","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T14:14:08Z","timestamp":1706105648000},"page":"5219-5232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Novel effect of topical Roquinimex and its combination with Clobetasol on an imiquimod-induced model of psoriasis in mice"],"prefix":"10.1007","volume":"397","author":[{"given":"Abeer Mohammed","family":"Hasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad Kadhim","family":"Gatea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"issue":"1","key":"2947_CR1","first-page":"32","volume":"35","author":"AR Abu-Raghif","year":"2015","unstructured":"Abu-Raghif AR, Sahib HB, Hanoon MMJ (2015) Antiangiogenic activity of Zizyphus spinachristi Leaves Extracts. Int J Pharm Sci Rev Res 35(1):32","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"6","key":"2947_CR2","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s00018-020-03726-1","volume":"78","author":"IS Afonina","year":"2021","unstructured":"Afonina IS, Van Nuffel E, Beyaert R (2021) Immune responses and therapeutic options in psoriasis. Cell Mol Life Sci 78(6):2709\u20132727","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2947_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.25130\/tjphs.2022.16.1.2.9.18","volume":"16","author":"NH Ahmed","year":"2022","unstructured":"Ahmed NH, Al-Zubaidy AAK, Qasim BJ (2022) Effect of tadalafil in comparison with clobetasol ointment in induced psoriasis in mice male. Tikrit J Pharma Sci 16(1):9\u201318","journal-title":"Tikrit J Pharma Sci"},{"key":"2947_CR4","unstructured":"Al-juhaishi AMR, Al-Zubaidy AAK, Al-Mousawy JMM (2021) Effects Of Montelukast On Imiquimod-Induced Model Of Psoriasis In Mice:3160-71"},{"issue":"2","key":"2947_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.26452\/ijrps.v10i2.255","volume":"10","author":"H Alsaedi","year":"2019","unstructured":"Alsaedi H, Al-Saedi H, Al-Zubaidy A, Ramadhan M, Mohammad HJ (2019) Effect of metformin gel against imiquimod\u2013induced psoriasis in mice. Int J Pharm Sci Res 10(2):795\u2013802","journal-title":"Int J Pharm Sci Res"},{"issue":"19","key":"2947_CR6","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. Jama 323(19):1945\u20131960","journal-title":"Jama"},{"issue":"2","key":"2947_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1568010043343886","volume":"3","author":"K Asadullah","year":"2004","unstructured":"Asadullah K, Sabat R, Friedrich M, Volk HD, Sterry WJ, Allergy. (2004) Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets-Inflam Allergy 3(2):185\u2013192","journal-title":"Curr Drug Targets-Inflam Allergy"},{"issue":"5","key":"2947_CR8","first-page":"959","volume":"32","author":"M Badanthadka","year":"2021","unstructured":"Badanthadka M, D\u2019Souza L (2021) Salwa FJJoB, Physiology C, Pharmacology. Strain Spec Resp Mice IMQ-Induced Psoriasis 32(5):959\u2013968","journal-title":"Strain Spec Resp Mice IMQ-Induced Psoriasis"},{"issue":"9","key":"2947_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00403-012-1272-y","volume":"304","author":"JO Baek","year":"2012","unstructured":"Baek JO, Byamba D, Wu WH, Kim TG, Lee MG (2012) Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress. Arch Dermatol Res 304(9):699\u2013706","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"2947_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2133.1992.tb08394.x","volume":"126","author":"BS Baker","year":"1992","unstructured":"Baker BS, Fry L (1992) The immunology of psoriasis. Br J Dermatol 126(1):1\u20139","journal-title":"Br J Dermatol"},{"issue":"12","key":"2947_CR11","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/j.1468-3083.2011.04332.x","volume":"26","author":"R Bissonnette","year":"2012","unstructured":"Bissonnette R, Bolduc C, Maari C, Nigen S, Webster J, Tang L et al (2012) Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial. J Eur Acad Dermatol Venereol 26(12):1516\u20131521","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2947_CR12","doi-asserted-by":"publisher","first-page":"892914","DOI":"10.3389\/fphar.2022.892914","volume":"13","author":"ESGA Borges","year":"2022","unstructured":"Borges ESGA, Bhattacharya T, Mamledesai S, Ai Z, Hasan AM, Cavalu S (2022) Identification of linomide derivatives as potential anticancer therapeutics using molecular docking studies. Front Pharmacol 13:892914","journal-title":"Front Pharmacol"},{"issue":"6","key":"2947_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1101\/pdb.prot073411","volume":"2014","author":"RD Cardiff","year":"2014","unstructured":"Cardiff RD, Miller CH, Munn RJ (2014) Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc 2014(6):655\u2013658","journal-title":"Cold Spring Harb Protoc"},{"key":"2947_CR14","doi-asserted-by":"crossref","unstructured":"Carvalho MFP, Pereira CSB, Fregnani JH, Ribeiro FAQ (2015) Comparative histological study on wound healing on rat\u2019s skin treated with Mitomycin C or Clobetasol propionate. Acta Cir Bras:30","DOI":"10.1590\/S0102-865020150090000002"},{"issue":"4","key":"2947_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0976-500X.119726","volume":"4","author":"J Charan","year":"2013","unstructured":"Charan J, Kantharia ND (2013) How to calculate sample size in animal studies? J Pharmacol Pharmacother 4(4):303\u2013306","journal-title":"J Pharmacol Pharmacother"},{"key":"2947_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","volume":"48","author":"H Chen","year":"2017","unstructured":"Chen H, Lu C, Liu H, Wang M, Zhao H, Yan Y, Han LJ (2017) Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway. Int Immunopharmacol 48:110\u2013117","journal-title":"Int Immunopharmacol"},{"key":"2947_CR17","unstructured":"Convention U, editor (n.d.) The United States pharmacopeia and national formulary; USP 37-NF 322014: US Pharmacopeial Convention Rockville, MD"},{"issue":"1","key":"2947_CR18","doi-asserted-by":"publisher","first-page":"2248318","DOI":"10.1080\/09546634.2023.2248318","volume":"34","author":"J Cui","year":"2023","unstructured":"Cui J, Zhang X, Deng J, Yan Y, Yao D, Deng H et al (2023) Potential biomarkers for psoriasis topical treatment by in-depth serum proteomics. J Dermatol Treat 34(1):2248318","journal-title":"J Dermatol Treat"},{"issue":"7","key":"2947_CR19","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/pros.20573","volume":"67","author":"SL Dalrymple","year":"2007","unstructured":"Dalrymple SL, Becker RE, Isaacs JT (2007) The quinoline-3-carboxamide antiangiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts. Prostate 67(7):790\u2013797","journal-title":"Prostate"},{"issue":"2","key":"2947_CR20","first-page":"22","volume":"13","author":"JQ Del Rosso","year":"2020","unstructured":"Del Rosso JQ (2020) Topical corticosteroid therapy for psoriasis-a review of clobetasol propionate 0.025% cream and the clinical relevance of penetration modification. J Clinical Aesthetic Dermatol 13(2):22\u201329","journal-title":"J Clinical Aesthetic Dermatol"},{"issue":"3","key":"2947_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","volume":"50","author":"Y Deng","year":"2016","unstructured":"Deng Y, Chang C, Lu Q (2016) The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol 50(3):377\u2013389","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"2947_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/S0165-5728(98)00023-X","volume":"85","author":"A Diab","year":"1998","unstructured":"Diab A, Michael L, Wahren B, Deng GM, Bj\u00f6rk J, Hedlund G, Zhu J (1998) Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of proinflammatory versus anti-inflammatory cytokines. J Neuroimmunol 85(2):146\u2013154","journal-title":"J Neuroimmunol"},{"key":"2947_CR23","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fphar.2022.892914","volume":"13","author":"GA Borges e Soares","year":"2022","unstructured":"Borges e Soares GA, Bhattacharya T, Mamledesai S, Ai Z, Hasan AM, Cavalu SJ (2022) Identification of linomide derivatives as potential anticancer therapeutics using molecular docking studies. Front Pharmacol 13:2173","journal-title":"Front Pharmacol"},{"issue":"2","key":"2947_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/jid.2012.318","volume":"133","author":"K El Malki","year":"2013","unstructured":"El Malki K, Karbach SH, Huppert J, Zayoud M, Reissig S, Sch\u00fcler R et al (2013) An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J Invest Dermatol 133(2):441\u2013451","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2947_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175\u2013191","journal-title":"Behav Res Methods"},{"issue":"1","key":"2947_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ilar.47.1.5","volume":"47","author":"MFW Festing","year":"2006","unstructured":"Festing MFW (2006) Design and statistical methods in studies using animal models of development. ILAR J 47(1):5\u201314","journal-title":"ILAR J"},{"issue":"4","key":"2947_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"2009","unstructured":"Fredriksson T, Pettersson U (2009) Severe psoriasis \u2013 oral therapy with a new retinoid. Dermatologica. 157(4):238\u2013244","journal-title":"Dermatologica."},{"issue":"9","key":"2947_CR28","first-page":"3","volume":"16","author":"LW Fu","year":"2011","unstructured":"Fu LW, Vender RBJ (2011) Newer approaches in topical combination therapy for acne. Skin Therapy Lett 16(9):3\u20136","journal-title":"Skin Therapy Lett"},{"issue":"03","key":"2947_CR29","first-page":"223","volume":"27","author":"TT Gaude","year":"2017","unstructured":"Gaude TT, e Soares GA, Priolkar RN, Biradar B, Mamledesai S (2017) Synthesis of 4-Hydroxy-1-(phenyl\/methyl)-3-[3-(substituted amino)-2-nitropropanoyl] quinolin-2 (1H)-ones as Antimicrobial and Antitubercular Agents. Indian J Heterocycl Chem 27(03):223\u2013228","journal-title":"Indian J Heterocycl Chem"},{"issue":"5","key":"2947_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.stemcr.2017.09.025","volume":"9","author":"M Gialitakis","year":"2017","unstructured":"Gialitakis M, Tolaini M, Li Y, Pardo M, Yu L, Toribio A et al (2017) Activation of the aryl hydrocarbon receptor interferes with early embryonic development. Stem Cell Rep 9(5):1377\u20131386","journal-title":"Stem Cell Rep"},{"issue":"2 Suppl 2","key":"2947_CR31","first-page":"S36","volume":"35","author":"LS Gold","year":"2016","unstructured":"Gold LS (2016) Topical therapies for psoriasis: improving management strategies and patient adherence. Semin Cutan Med Surg 35(2 Suppl 2):S36\u2013S44","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"2947_CR32","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.xjidi.2021.100007","volume":"1","author":"GC Gondo","year":"2021","unstructured":"Gondo GC, Koons S, Metcalf C, Bell SJ, Mehta NN (2021a) Viewing psoriasis as a systemic disease for better health outcomes. JID Innov 1(2):100007","journal-title":"JID Innov"},{"key":"2947_CR33","doi-asserted-by":"crossref","unstructured":"Gondo GC, Koons S, Metcalf C, Bell SJ, Mehta NNJJI (2021b) Viewing psoriasis as a systemic disease for better health outcomes.1(2)","DOI":"10.1016\/j.xjidi.2021.100007"},{"issue":"10281","key":"2947_CR34","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J (2021) Psoriasis. Lancet (London, England) 397(10281):1301\u20131315","journal-title":"Lancet (London, England)"},{"issue":"1","key":"2947_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","unstructured":"Guti\u00e9rrez-V\u00e1zquez C, Quintana FJJI (2018) Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48(1):19\u201333","journal-title":"Immunity"},{"issue":"11","key":"2947_CR36","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jid.2016.06.627","volume":"136","author":"K Haas","year":"2016","unstructured":"Haas K, Weighardt H, Deenen R, K\u00f6hrer K, Clausen B, Zahner S et al (2016) Aryl hydrocarbon receptor in keratinocytes is essential for murine skin barrier integrity. J Invest Dermatol 136(11):2260\u20132269","journal-title":"J Invest Dermatol"},{"key":"2947_CR37","doi-asserted-by":"publisher","unstructured":"Hasan AM, Hasan AM. (2023a). Topical Roquinimex and its combination with Clobetasol [Data set]. Zenodo. 2023. https:\/\/doi.org\/10.5281\/zenodo.8423291","DOI":"10.5281\/zenodo.8423291"},{"key":"2947_CR38","unstructured":"Hasan AM, Hasan AM (2023b) ARRIVE guidelines 2.0: author checklist. 2023.\u00a0https:\/\/zenodo.org\/doi\/10.5281\/zenodo.8423300"},{"issue":"10","key":"2947_CR39","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3987\/COM-12-12523","volume":"85","author":"HM Hassanin","year":"2012","unstructured":"Hassanin HM, El-edfawy SM (2012) Novel heterocyclic derivatives of 2-quinolinone associated with antibacterial and antitumor potencies. Heterocycles: Int J Rev Commun heterocyc Chem 85(10):2421\u20132436","journal-title":"Heterocycles: Int J Rev Commun heterocyc Chem"},{"key":"2947_CR40","doi-asserted-by":"crossref","unstructured":"Ioannidou E, Moschetta M, Shah S, Parker JS, Ozturk MA, Pappas-Gogos G et al (2021) Angiogenesis and antiangiogenic treatment in prostate cancer: mechanisms of action and molecular targets. Int J Mol Sci 22(18)","DOI":"10.3390\/ijms22189926"},{"issue":"4","key":"2947_CR41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/ijms21041215","volume":"21","author":"N Irrera","year":"2020","unstructured":"Irrera N, Bitto A, Vaccaro M, Mannino F, Squadrito V, Pallio G et al (2020) PDRN, a bioactive natural compound,0020ameliorates imiquimod-induced psoriasis through NF-\u03baB pathway inhibition and Wnt\/\u03b2-catenin signaling modulation. Int J Mol Sci 21(4):1215","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2947_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1517\/13543784.2010.514262","volume":"19","author":"JT Isaacs","year":"2010","unstructured":"Isaacs JT (2010) The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer. Expert Opin Investig Drugs 19(10):1235\u20131243","journal-title":"Expert Opin Investig Drugs"},{"issue":"16","key":"2947_CR43","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/pros.20509","volume":"66","author":"JT Isaacs","year":"2006","unstructured":"Isaacs JT, Pili R, Qian DZ, Dalrymple SL, Garrison JB, Kyprianou N et al (2006) Identification of ABR-215050 as lead second generation quinoline-3-carboxamide antiangiogenic agent for the treatment of prostate cancer. Prostate 66(16):1768\u20131778","journal-title":"Prostate"},{"issue":"9","key":"2947_CR44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/pharmaceutics12090789","volume":"12","author":"M Jabeen","year":"2020","unstructured":"Jabeen M, Boisgard A-S, Danoy A, El Kholti N, Salvi J-P, Boulieu R et al (2020) Advanced characterization of imiquimod-induced psoriasis-like mouse model. Pharmaceutics 12(9):789","journal-title":"Pharmaceutics"},{"key":"2947_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biochi.2016.01.013","volume":"123","author":"D Kang","year":"2016","unstructured":"Kang D, Li B, Luo L, Jiang W, Lu Q, Rong M, Lai R (2016) Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie. 123:73\u201380","journal-title":"Biochimie."},{"issue":"2","key":"2947_CR46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1055\/s-0032-1331711","volume":"63","author":"MS Katagi","year":"2013","unstructured":"Katagi MS, Bolakatti GS, Badiger AM, Satyanarayana D, Mamledesai SN, Sujatha ML (2013) Synthesis, spectral characterization and antimicrobial activity of substituted thiazolyl derivatives of 2-quinolones. Drug Res (Stuttg) 63(2):53\u201359","journal-title":"Drug Res (Stuttg)"},{"key":"2947_CR47","doi-asserted-by":"crossref","unstructured":"Khamees A, Fawzi H, Sahib H (2020) Phytochemical investigation and assessment of the hypoglycemic activity of two herbal extracts from selected Iraqi medicinal plants in alloxan-stimulated diabetic rats: a comparative study [version 1; peer review: 2 approved with reservations]. F1000Res.9(247)","DOI":"10.12688\/f1000research.22788.1"},{"issue":"4","key":"2947_CR48","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3923\/ijp.2018.546.552","volume":"14","author":"AH Khamees","year":"2018","unstructured":"Khamees AH, Abdulhussein AJ, Sahib HB, Fawzi HA (2018) Antiangiogenic and antioxidant activity of iraqi cyperus rotundus ethanol extract. Int J Pharmacol 14(4):546\u2013552","journal-title":"Int J Pharmacol"},{"issue":"2","key":"2947_CR49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/gels9020112","volume":"9","author":"R Khan","year":"2023","unstructured":"Khan R, Mirza MA, Aqil M, Alex TS, Raj N, Manzoor N et al (2023) In vitro and in vivo investigation of a dual-targeted nanoemulsion gel for the amelioration of psoriasis. Gels 9(2):112","journal-title":"Gels"},{"issue":"8","key":"2947_CR50","first-page":"643","volume":"12","author":"M Kimura","year":"1986","unstructured":"Kimura M, Tarumoto Y, Nakane S, Otomo S (1986) Comparative toxicity study of hydrocortisone 17-butyrate 21-propionate (HBP) ointment and other topical corticosteroids in rats. Drugs Exp Clin Res 12(8):643\u2013652","journal-title":"Drugs Exp Clin Res"},{"key":"2947_CR51","first-page":"311","volume-title":"Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments","author":"EC Kleyn","year":"2019","unstructured":"Kleyn EC, Morsman E, Griffin L, Wu JJ, Cm van de Kerkhof P, Gulliver W et al (2019) Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments. Taylor & Francis, pp 311\u2013319"},{"key":"2947_CR52","doi-asserted-by":"publisher","first-page":"111605","DOI":"10.1016\/j.msec.2020.111605","volume":"119","author":"S Kumar","year":"2021","unstructured":"Kumar S, Prasad M, Rao R (2021) Topical delivery of clobetasol propionate loaded nanosponge hydrogel for effective treatment of psoriasis: formulation, physicochemical characterization, antipsoriatic potential and biochemical estimation. Mater Sci Eng C 119:111605","journal-title":"Mater Sci Eng C"},{"issue":"24","key":"2947_CR53","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.3390\/jcm10245834","volume":"10","author":"M Kutwin","year":"2021","unstructured":"Kutwin M, Migdalska-S\u0119k M, Brzezia\u0144ska-Lasota E, Zelga P, Wo\u017aniacka AJ (2021) An analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R expression and their correlation with clinical course in patients with psoriasis. J Clin Med 10(24):5834","journal-title":"J Clin Med"},{"issue":"7 Suppl 1","key":"2947_CR54","first-page":"S7","volume":"13","author":"JA Lequang","year":"2020","unstructured":"Lequang JA (2020) Dermatology A. Updates in psoriasis management: based on selected presentations from Maui Derm 2020, January 25\u201329, 2020, Maui, Hawaii. J Clin Aesthetic Dermatol 13(7 Suppl 1):S7","journal-title":"J Clin Aesthetic Dermatol"},{"key":"2947_CR55","doi-asserted-by":"crossref","unstructured":"Mason AR, Mason J, Cork M, Dooley G, Hancock H (2013) Topical treatments for chronic plaque psoriasis. Cochrane Database System Rev (3):Cd005028","DOI":"10.1002\/14651858.CD005028.pub3"},{"issue":"2","key":"2947_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Euro Acad Dermatol Venereology : JEADV 31(2):205\u2013212","journal-title":"J Euro Acad Dermatol Venereology : JEADV"},{"issue":"S3","key":"2947_CR57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.53730\/ijhs.v6nS3.5241","volume":"6","author":"SS Mohammed","year":"2022","unstructured":"Mohammed SS, Kadhim HM, Al-Sudani IM, Musatafa WW (2022a) Study the topical effect of six days use of different lycopene doses on imiquimod-induce psoriasis-like skin inflammation in mice. Int J Health Sci 6(S3):171\u2013185","journal-title":"Int J Health Sci"},{"key":"2947_CR58","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.25258\/ijddt.12.3.53","volume":"12","author":"SS Mohammed","year":"2022","unstructured":"Mohammed SS, Kadhim HM, Al-Sudani IM, Musatafa WW (2022b) Anti-inflammatory effects of topically applied azilsartan in a mouse model of imiquimod-induced psoriasis. Int J Drug Deliv Technol 12:1249\u20131255","journal-title":"Int J Drug Deliv Technol"},{"issue":"5","key":"2947_CR59","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","volume":"139","author":"S Moos","year":"2019","unstructured":"Moos S, Mohebiany AN, Waisman A, Kurschus FC (2019) Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J Investig Dermatol 139(5):1110\u20131117","journal-title":"J Investig Dermatol"},{"key":"2947_CR60","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.phrs.2015.06.001","volume":"99","author":"A Nadeem","year":"2015","unstructured":"Nadeem A, Al-Harbi NO, Al-Harbi MM, El-Sherbeeny AM, Ahmad SF, Siddiqui N et al (2015) Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC\/IL-17A pathway modulation. Pharmacol Res 99:248\u2013257","journal-title":"Pharmacol Res"},{"issue":"2","key":"2947_CR61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/pharmaceutics14020383","volume":"14","author":"AB Nair","year":"2022","unstructured":"Nair AB, Kumar S, Dalal P, Nagpal C, Dalal S, Rao R et al (2022) Novel dermal delivery cargos of clobetasol propionate: an update. Pharmaceutics 14(2):383","journal-title":"Pharmaceutics"},{"issue":"9","key":"2947_CR62","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1212\/WNL.54.9.1726","volume":"54","author":"J Noseworthy","year":"2000","unstructured":"Noseworthy J, Wolinsky J, Lublin F, Whitaker J, Linde A, Gjorstrup P et al (2000) Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results. Neurology 54(9):1726\u20131733","journal-title":"Neurology"},{"key":"2947_CR63","doi-asserted-by":"crossref","unstructured":"Nunes A, Marto J, Gon\u00e7alves LM, Sim\u00f5es S, F\u00e9lix R, Ascenso A et al (2020) Novel and modified neutrophil elastase inhibitor loaded in topical formulations for psoriasis management. Pharmaceutics. 12(4)","DOI":"10.3390\/pharmaceutics12040358"},{"key":"#cr-split#-2947_CR64.1","doi-asserted-by":"crossref","unstructured":"Ocampo DV, Gladman D (2019) Psoriatic arthritis [version 1","DOI":"10.1093\/oso\/9780199231225.003.0001"},{"key":"#cr-split#-2947_CR64.2","unstructured":"peer review: 2 approved]. F1000Res. 8(1665)"},{"issue":"4","key":"2947_CR65","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Gen 38(4):441\u2013446","journal-title":"Nature Gen"},{"issue":"4","key":"2947_CR66","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/08916939808995371","volume":"28","author":"O Pekarski","year":"1998","unstructured":"Pekarski O, Bj\u00f6rk J, Hedlund G, Andersson G (1998) The inhibitory effect in experimental autoimmune encephalomyelitis by the immunomodulatory drug Linomide (PNU-212616) is not mediated via release of endogenous glucocorticoids. Autoimmunity. 28(4):235\u2013241","journal-title":"Autoimmunity."},{"issue":"2","key":"2947_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/bcpt.12774","volume":"121","author":"P Pierozan","year":"2017","unstructured":"Pierozan P, Jerner\u00e9n F, Ransome Y, Karlsson O (2017) The choice of euthanasia method affects metabolic serum biomarkers. Basic Clin Pharmacol Toxicol 121(2):113\u2013118","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2947_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.biopha.2018.07.156","volume":"107","author":"M Pradhan","year":"2018","unstructured":"Pradhan M, Alexander A, Singh MR, Singh D, Saraf S, Saraf S, Ajazuddin. (2018) Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacotherapy = Biomed Pharmaco 107:447\u2013463","journal-title":"Biomed Pharmacotherapy = Biomed Pharmaco"},{"key":"2947_CR69","doi-asserted-by":"crossref","unstructured":"Prokopec SD, Pohjanvirta R, Mahiout S, Pettersson L, Boutros PC (2019) Transcriptomic impact of IMA-08401, a novel AHR agonist resembling laquinimod, on rat liver. Int J Mol Sci 20(6)","DOI":"10.3390\/ijms20061370"},{"issue":"2","key":"2947_CR70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.adengl.2020.01.001","volume":"111","author":"A Reolid","year":"2020","unstructured":"Reolid A, Servitje O, Ginarte M, P\u00e9rez-Ferriols A, V\u00e9lez A, Arag\u00fces M et al (2020) Validation of an optical pencil method to estimate the affected body surface area in psoriasis. Actas Dermo-Sifiliogr\u00e1ficas (English Edition) 111(2):143\u2013148","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"key":"2947_CR71","doi-asserted-by":"crossref","unstructured":"Rikken G, van den Brink NJM, van Vlijmen-Willems I, van Erp PEJ, Pettersson L, Smits JPH, van den Bogaard EH (2022a) Carboxamide derivatives are potential therapeutic AHR ligands for restoring IL-4 mediated repression of epidermal differentiation proteins. Int J Mol Sci 23(3)","DOI":"10.3390\/ijms23031773"},{"issue":"3","key":"2947_CR72","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/ijms23031773","volume":"23","author":"G Rikken","year":"2022","unstructured":"Rikken G, van den Brink NJM, van Vlijmen-Willems IMJJ, van Erp PEJ, Pettersson L, Smits JPH, van den Bogaard EH (2022b) Carboxamide derivatives are potential therapeutic AHR ligands for restoring IL-4 mediated repression of epidermal differentiation proteins. Int J Mol Sci 23(3):1773","journal-title":"Int J Mol Sci"},{"key":"2947_CR73","doi-asserted-by":"crossref","unstructured":"Salman HR, Al-Zubaidy AA, Abbas AH (2023) Zigam QAJN-SsAoP. The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice:1-18","DOI":"10.1007\/s00210-023-02629-9"},{"issue":"6","key":"2947_CR74","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","volume":"15","author":"S Schoepe","year":"2006","unstructured":"Schoepe S, Sch\u00e4cke H, May E, Asadullah KJ (2006) Glucocorticoid Therapy-induced Skin Atrophy. Exp Dermatol 15(6):406\u2013420","journal-title":"Exp Dermatol"},{"issue":"1","key":"2947_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/09546634.2020.1729335","volume":"33","author":"S Segaert","year":"2022","unstructured":"Segaert S, Calzavara-Pinton P, de la Cueva P, Jalili A, Lons Danic D, Pink AE et al (2022) Long-term topical management of psoriasis: the road ahead. J Dermatol Treat 33(1):111\u2013120","journal-title":"J Dermatol Treat"},{"issue":"Suppl 1","key":"2947_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2131\/jts.7.SupplementI_15","volume":"7","author":"T Shimo","year":"1982","unstructured":"Shimo T, Takahara Y, Noguchi Y, Mukawa A, Kato H, Ito Y (1982) Comparative toxicity test of dexamethasone valerate (DV-17) and other steroid ointments in rats. J Toxicol Sci 7(Suppl 1):15\u201333","journal-title":"J Toxicol Sci"},{"issue":"23","key":"2947_CR77","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.3390\/ijms222312793","volume":"22","author":"R Singh","year":"2021","unstructured":"Singh R, Koppu S, Perche PO, Feldman SR (2021) The cytokine mediated molecular pathophysiology of psoriasis and its clinical implications. Int J Mol Sci 22(23):12793","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2947_CR78","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.jid.2020.03.605","volume":"140","author":"S Smith","year":"2020","unstructured":"Smith S, McHale K, Creech K, Rickard D, Jayawickreme C, Wu D et al (2020) 595 Differential ligand binding distinguishes therapeutic from pathologic Aryl Hydrocarbon Receptor (AhR) modulating agents: implications for inflammatory skin disease. J Investig Dermatol 140(7):S81","journal-title":"J Investig Dermatol"},{"issue":"10","key":"2947_CR79","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40261-021-01072-z","volume":"41","author":"SY Tan","year":"2021","unstructured":"Tan SY, Chandran NS, Choi EC-E (2021) Steroid phobia: is there a basis? A review of topical steroid safety, addiction and withdrawal. Clinical Drug Invest 41(10):835\u2013842","journal-title":"Clinical Drug Invest"},{"key":"2947_CR80","doi-asserted-by":"crossref","unstructured":"Tian X, Tang L, Wei F, Chen H, Sheng L, Yang Y, et al. (2021) Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells.132:30-40","DOI":"10.1016\/j.molimm.2021.01.019"},{"issue":"8","key":"2947_CR81","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chom.2021.05.011","volume":"29","author":"A Uberoi","year":"2021","unstructured":"Uberoi A, Bartow-McKenney C, Zheng Q, Flowers L, Campbell A, Knight SA et al (2021) Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor. Cell Host Microbe 29(8):1235\u20131248 e8","journal-title":"Cell Host Microbe"},{"key":"2947_CR82","unstructured":"Underwood W, Anthony R (2013) AVMA guidelines for the euthanasia of animals: 2020 edition. Retrieved on March. 2020;(30):2020-1"},{"issue":"5","key":"2947_CR83","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/jid.2015.6","volume":"135","author":"EH Van Den Bogaard","year":"2015","unstructured":"Van Den Bogaard EH, Podolsky MA, Smits JP, Cui X, John C, Gowda K et al (2015) Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation. J Invest Dermatol 135(5):1320\u20131328","journal-title":"J Invest Dermatol"},{"issue":"9","key":"2947_CR84","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD et al (2009) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182(9):5836\u20135845","journal-title":"J Immunol"},{"issue":"9","key":"2947_CR85","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van Der Fits","year":"2009","unstructured":"Van Der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD et al (2009a) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J Immunol 182(9):5836\u20135845","journal-title":"J Immunol"},{"issue":"9","key":"2947_CR86","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van Der Fits","year":"2009","unstructured":"Van Der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD et al (2009b) Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J\\ Immunol 182(9):5836\u20135845","journal-title":"J\\ Immunol"},{"issue":"1","key":"2947_CR87","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12(1):64\u201382","journal-title":"Nat Rev Drug Discov"},{"key":"2947_CR88","volume-title":"Comprehensive dermatologic drug therapy","author":"SE Wolverton","year":"2019","unstructured":"Wolverton SE, Wu JJ (2019) Comprehensive dermatologic drug therapy. Elsevier Health Sciences"},{"issue":"2","key":"2947_CR89","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.imlet.2007.09.001","volume":"114","author":"ZY Xiao","year":"2007","unstructured":"Xiao ZY, Zhou WX, Zhang YX, Cheng JP, He JF, Yang RF, Yun LH (2007) Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264.7 macrophages through suppression of NF-kappaB, p38, and JNK activation. Immunol Lett 114(2):81\u201385","journal-title":"Immunol Lett"},{"key":"2947_CR90","doi-asserted-by":"publisher","first-page":"110322","DOI":"10.1016\/j.mehy.2020.110322","volume":"145","author":"K Yadav","year":"2020","unstructured":"Yadav K, Singh D, Singh MR, Pradhan M (2020) Multifaceted targeting of cationic liposomes via co-delivery of anti-IL-17 siRNA and corticosteroid for topical treatment of psoriasis. Med Hypotheses 145:110322","journal-title":"Med Hypotheses"},{"key":"2947_CR91","unstructured":"Yousefzadeh H, Azad FJ, Rastin M, Banihashemi M, Mahmoudi MJ, Biology M (2017b) Expression of Th1 and Th2 cytokine and associated transcription factors in peripheral blood mononuclear cells and correlation with disease severity.;6(1):102"},{"issue":"1","key":"2947_CR92","first-page":"102","volume":"6","author":"H Yousefzadeh","year":"2017","unstructured":"Yousefzadeh H, Jabbari Azad F, Rastin M, Banihashemi M, Mahmoudi M (2017a) Expression of Th1 and Th2 cytokine and associated transcription factors in peripheral blood mononuclear cells and correlation with disease severity. Rep Biochem Mole Bio 6(1):102\u2013111","journal-title":"Rep Biochem Mole Bio"},{"issue":"1","key":"2947_CR93","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1038\/s41467-022-33734-7","volume":"13","author":"D Zhang","year":"2022","unstructured":"Zhang D, Ning J, Ramprasath T, Yu C, Zheng X, Song P et al (2022) Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis. Nat Commun 13(1):6371","journal-title":"Nat Commun"},{"issue":"4","key":"2947_CR94","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2174\/156800805774912926","volume":"5","author":"X Zhou","year":"2005","unstructured":"Zhou X, Schmidtke P, Zepp F, Meyer CU (2005) Endocrine, Disorders M. Boosting interleukin-10 production: therapeutic effects and mechanisms. Curr Drug Targets-Immune, Endocrine Meta Dis 5(4):465\u2013475","journal-title":"Curr Drug Targets-Immune, Endocrine Meta Dis"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-02947-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-02947-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-02947-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T01:15:31Z","timestamp":1731114931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-02947-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2947"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-02947-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"10 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the \u201cResearch Ethics Committee at the College of Medicine, Al-Nahrain University\u201d (Approval number: 2308, date: 1<sup>st<\/sup> November 2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}